| CITATION: | Pharmacy Board of Australia v Beattie [2012] QCAT 550 |
| PARTIES: | Pharmacy Board of Australia |
| v | |
| Elizabeth Nita Beattie |
| APPLICATION NUMBER: | OCR297-11 |
| MATTER TYPE: | Occupational regulation matters |
| HEARING DATE: | 24 September 2012 |
| HEARD AT: | Brisbane |
| DECISION OF: | Kerrie O'Callaghan, Acting Deputy President Assisted by: Karen Allen Graeme Lawrence Pamela Mathers |
| DELIVERED ON: | 6 November 2012 |
| DELIVERED AT: | Brisbane |
| ORDERS MADE: | 1. Mrs Beattie is cautioned. 2. Each party must bear their own costs. |
APPEARANCES and REPRESENTATION (if any):
| APPLICANT: | Pharmacy Board of Australia represented by Mr Andrew Preston, instructed by DLA Piper |
| RESPONDENT: | Mrs Elizabeth Nita Beattie represented by Ms Stephanie Gallagher, instructed by Shand Taylor Lawyers |
REASONS FOR DECISION
Mrs Beattie registered as a pharmacist in 1971 and has since worked in Brisbane and various rural areas. In 1979 Mrs Beattie purchased Speirs Pharmacy in Longreach and relocated. She is currently the owner of Speirs Pharmacy Longreach, the Longreach Pharmacy and the Cloncurry Pharmacy. She manages Speirs Pharmacy Longreach and employs managers for the other two. All pharmacies are accredited. Up until these proceedings Mrs Beattie had never been the subject of a complaint or had disciplinary proceedings taken against her.
The Pharmacy Board of Australia has brought these disciplinary proceedings against Mrs Beattie for inappropriately dispensing pseudoephedrine (‘PSE’) products by failing to adequately make and maintain records in regards to the dispensing of PSE products.
The Conduct
On 14 July 2009 Queensland Health conducted an audit of Speirs Pharmacy Longreach (‘the Pharmacy’). The audit found that between 1 July 2007 and 14 July 2009 (‘the audit period’):
a.871 units of PSE were obtained by the Pharmacy;
b.The sales of 225 units of PSE were recorded in the Pharmacy’s dispensing software;
c.There were no records for 646 units of PSE.
PSE is a substance prone to misuse and abuse. It is used in the manufacture of methylamphetamine, the drug also known as ‘speed’ or ‘ice’.
In 2006 PSE…
Keep reading for free
Create a free CaseChat account to read Pharmacy Board of Australia v Beattie and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2012] QCAT 550
- Decision Date
CaseChat Overview and Summary
The central legal issues before the AAT were whether Mrs Beattie's failure to maintain proper records of PSE sales amounted to professional misconduct, and if so, what the appropriate sanction should be. The AAT needed to assess the gravity of the breach, consider relevant statutory and regulatory provisions, and examine the impact of the failure on the public interest and professional standards.
In reaching its decision, the AAT closely examined the evidence presented regarding Mrs Beattie's record-keeping practices. It concluded that while the failure to maintain proper records was a significant lapse, the overall evidence did not support a finding of professional misconduct warranting a formal caution. The Tribunal found that the breach, although serious, did not rise to the level of professional misconduct that would typically result in more severe disciplinary action. Consequently, the AAT ordered that Mrs Beattie be cautioned and that each party bear their own costs.
Orders
Orders of the court
1. Mrs Beattie is cautioned.
2. Each party must bear their own costs.
Background
Background to the litigation
Evidence
Evidence Before The Court
Decision
Reasons for decision
Ratio Decidendi